BioSpace News Archive

Policy

The EndBrainCancer Initiative Urges Immediate ACTION so Brain Cancer Patients are Not Excluded from Medicare Coverage for Genetic Profiling (Next Generation Sequencing-NGS)

In 2018, the Centers for Medicaid and Medicare Services approved funding for specific diagnostic tests associated with genomic profiling, both for predictive usages and for analysis for cancer patients with recurrent, relapsed, refractory, metastatic, and/or advanced Stages III and IV cancers.

May 28, 2019
·
2 min read
Business

Covalon Announces Second Quarter Fiscal 2019 Results

Covalon Technologies Ltd., an advanced medical technologies company, announced its second quarter fiscal 2019 results.

May 28, 2019
·
5 min read
FDA

Incyte’s Jakafi Snags FDA Approval for Treatment of Steroid-Refractory Acute GVHD

The approval of Jakafi marks the first approved treatment for this indication in the United States.

May 28, 2019
·
2 min read
·
Alex Keown
Drug Development

Newron Pharma Delays Schizophrenia Trials Over Safety Concerns

The agency expressed concern over the results of recently finished studies in rats and dogs that showed central nervous system events that might have implications in humans.

May 28, 2019
·
3 min read
·
Mark Terry
Drug Development

Pfizer’s Lyrica Misses the Mark in Epilepsy Clinical Trial

The patients receiving Lyrica didn’t show a statistically significant reduction in seizure frequency compared to placebo.

May 28, 2019
·
2 min read
·
Mark Terry
FDA

Novartis Wins Approval for First-of-its-Kind Breast Cancer Treatment

The approval of Piqray combined with fulvestrant is the first FDA-approved treatment for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer.

May 28, 2019
·
2 min read
·
Alex Keown
Business

Eli Lilly In-Licenses Non-Opioid Drug from Centrexion in $997 Million-Plus Deal

Eli Lilly announced it has inked a license agreement with Centrexion Therapeutics to acquire the exclusive global rights to CNTX-0290.

May 28, 2019
·
3 min read
·
Mark Terry
FDA

FDA Approves Allergan’s Vraylar for Treatment of Bipolar Disorder

There are approximately 11 million adults in the U.S. living with bipolar disorder, a condition that causes extreme shifts in mood, energy and activity levels.

May 28, 2019
·
2 min read
·
Alex Keown
Career Advice

How to Efficiently Understand What an Organization is Looking For in a Job Description

Expending countless hours of time and energy usually leads to frustration and burnout during a job search. Here are some tips to understanding what a company is really looking for in a job description.

May 28, 2019
·
3 min read
·
Porschia Parker
BioCapital

ASCO 2019 Preview: Presentations to Keep An Eye On

With ASCO set to kick off on Friday, companies prepare to share data from multiple cancer treatment pipeline programs.

May 28, 2019
·
3 min read
·
Alex Keown